Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1991 1
1995 1
2004 1
2006 1
2008 6
2009 5
2010 7
2011 10
2012 6
2013 8
2014 10
2015 14
2016 12
2017 13
2018 17
2019 27
2020 32
2021 38
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

183 results
Results by year
Filters applied: . Clear all
Page 1
The chemistry and biological activities of N-acetylcysteine.
Samuni Y, Goldstein S, Dean OM, Berk M. Samuni Y, et al. Among authors: dean om. Biochim Biophys Acta. 2013 Aug;1830(8):4117-29. doi: 10.1016/j.bbagen.2013.04.016. Epub 2013 Apr 22. Biochim Biophys Acta. 2013. PMID: 23618697 Review.
An update on adjunctive treatment options for bipolar disorder.
Dean OM, Gliddon E, Van Rheenen TE, Giorlando F, Davidson SK, Kaur M, Ngo TT, Williams LJ. Dean OM, et al. Bipolar Disord. 2018 Mar;20(2):87-96. doi: 10.1111/bdi.12601. Epub 2018 Jan 25. Bipolar Disord. 2018. PMID: 29369487 Review.
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, Koutsogiannis J, Phelan M, Mullen E, Harrison BJ, Rice S, Parker AG, Dean OM, Weller A, Kerr M, Quinn AL, Catania L, Kazantzis N, McGorry PD, Berk M. Davey CG, et al. Among authors: dean om. Lancet Psychiatry. 2019 Sep;6(9):735-744. doi: 10.1016/S2215-0366(19)30215-9. Epub 2019 Jul 29. Lancet Psychiatry. 2019. PMID: 31371212 Clinical Trial.
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo.
Berk M, Turner A, Malhi GS, Ng CH, Cotton SM, Dodd S, Samuni Y, Tanious M, McAulay C, Dowling N, Sarris J, Owen L, Waterdrinker A, Smith D, Dean OM. Berk M, et al. Among authors: dean om. BMC Med. 2019 Jan 25;17(1):18. doi: 10.1186/s12916-019-1257-1. BMC Med. 2019. PMID: 30678686 Free PMC article. Clinical Trial.
The evolution of clinical trials in response to COVID-19.
Sarah A, Dean O, Berk M. Sarah A, et al. Among authors: dean o. Med J Aust. 2021 Apr;214(7):332-332.e1. doi: 10.5694/mja2.50991. Epub 2021 Mar 22. Med J Aust. 2021. PMID: 33749864 Free PMC article. No abstract available.
Mitochondrial Agents for Bipolar Disorder.
Pereira C, Chavarria V, Vian J, Ashton MM, Berk M, Marx W, Dean OM. Pereira C, et al. Among authors: dean om. Int J Neuropsychopharmacol. 2018 Jun 1;21(6):550-569. doi: 10.1093/ijnp/pyy018. Int J Neuropsychopharmacol. 2018. PMID: 29596661 Free PMC article. Review.
Statins: Neurobiological underpinnings and mechanisms in mood disorders.
Walker AJ, Kim Y, Borissiouk I, Rehder R, Dodd S, Morris G, Nierenberg AA, Maes M, Fernandes BS, Dean OM, Williams LJ, Eyre HA, Kim SW, Zoungas S, Carvalho AF, Berk M. Walker AJ, et al. Among authors: dean om. Neurosci Biobehav Rev. 2021 Sep;128:693-708. doi: 10.1016/j.neubiorev.2021.07.012. Epub 2021 Jul 13. Neurosci Biobehav Rev. 2021. PMID: 34265321 Review.
183 results